Dogwood Therapeutics, Inc. Earnings
The next earnings date for Dogwood Therapeutics, Inc. has not yet been scheduled.
Analyst Estimates of Dogwood Therapeutics, Inc. Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Dogwood Therapeutics, Inc. Earnings: Historical
| 11/05/2026 | --- | --- | --- |
| 08/13/2026 | Before Market | $-0.34 | -161.54% |
| 03/18/2026 | Before Market | $-0.26 | 69.77% |
| 11/06/2025 | Before Market | $-8.20 | -418.99% |
| 08/13/2025 | Before Market | $-1.99 | -4.74% |
| 05/08/2025 | Before Market | $-8.45 | -1,011.84% |
| 03/13/2025 | --- | $-6.29 | -10,993.48% |
| 11/07/2024 | Before Market | $-2.05 | -73.73% |
| 08/08/2024 | Before Market | $-1.25 | 20.89% |
| 05/09/2024 | Before Market | $-1.75 | -75.00% |
More About Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended to synergistically suppress herpesvirus activation; and Serpin Peptide 16 that is in early Phase 1 development to reduce neuropathy secondary to treat chemotherapeutic agents that are neurotoxic. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is based in Alpharetta, Georgia.
“Dogwood Therapeutics, Inc. Earnings” Can Refer to the Dogwood Therapeutics, Inc. Earnings Date
Some people say “Dogwood Therapeutics, Inc. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Dogwood Therapeutics, Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Dogwood Therapeutics, Inc. Stock on the Earnings Date
If you own Dogwood Therapeutics, Inc. stock (DWTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Dogwood Therapeutics, Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Dogwood Therapeutics, Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Dogwood Therapeutics, Inc. Earnings
You can contact us any time if you would like to ask questions about Dogwood Therapeutics, Inc. earnings or anything else related to the stock market.